MedPath
NMPA Approval

Daclatasvir Hydrochloride Tablets

国药准字H20223191

March 29, 2022

Drug Information

盐酸达拉他韦片

片剂

60 mg(按C40H50N8O6计算)

化学药品

March 29, 2022

Company Information

Applicant Company

南京市经济技术开发区惠中路9号

Manufacturing Company

南京经济技术开发区惠中路9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸达拉他韦片 - NMPA 批准文号 | MedPath